LINETSKY DAVID (SVP, Life Sciences) sold 2.6% of their position (6.11K shares) of PHREESIA, INC. on the open market
Open‑market sale worth $103.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/12/2026ACC: 0001412408-26-000016
Officer· SVP, Life Sciences
Since Jul 2019
-6.11K
Net shares
Net seller
$103.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.11K
Price / share
$17.01
Trade value
$103.85K
% of position
2.6%
1/8/2026
237.83K→231.72K
Total
Net shares
−6.11K
Net value
-$103.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2026 | S · Sale | −6.11K | $17.01 | $103.85K | 2.6% | 237.83K | 231.72K |
| Total | −6.11K | -$103.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned9.79K
Total
9.79K indirect9.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.79K | Indirect |
| Total | 9.79K | 9.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported